Monday, July 13, 2020 10:37:28 PM
Recent EQ News
- Equillium Announces Abstract Accepted for Poster Presentation at the Society for Immunotherapy of Cancer • Business Wire • 10/07/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 10:14:15 PM
- Equillium to Present at the Stifel Virtual Inflammation & Immunology Summit • Business Wire • 09/10/2024 12:00:00 PM
- Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/04/2024 12:00:00 PM
- Equillium to Present at the Wells Fargo Healthcare Conference and the H.C. Wainwright 26th Annual Global Investor Conference • Business Wire • 08/28/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 08:10:26 PM
- Equillium Reports Second Quarter 2024 Financial Results and Provides Recent Corporate and Clinical Highlights • Business Wire • 08/08/2024 08:01:00 PM
- Equillium Announces Positive Interim Analysis from Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease • Business Wire • 08/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:01:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/18/2024 06:08:53 PM
- Equillium Announces Second Quarter 2024 Estimated Cash and Investments Balance • Business Wire • 07/18/2024 05:57:00 PM
- Equillium to Participate in Upcoming Investor Conferences • Business Wire • 07/02/2024 12:00:00 PM
- Equillium to be included in the Russell Microcap® Index • Business Wire • 06/12/2024 12:00:00 PM
- Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 12:00:55 PM
- Equillium Announces Positive Topline Data from Phase 2 Study of EQ101 in Alopecia Areata • Business Wire • 06/04/2024 12:00:00 PM
- Equillium to Present at the Jefferies Global Healthcare Conference • Business Wire • 05/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/23/2024 09:56:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:00:15 PM
- Equillium Announces Interim Enrollment Achieved in Phase 3 EQUATOR Study of Itolizumab in Acute Graft-Versus-Host Disease • Business Wire • 05/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:11:09 PM
- Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights • Business Wire • 05/09/2024 08:01:00 PM
- Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists • Business Wire • 05/07/2024 12:00:00 PM
- Equillium Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 04/03/2024 12:00:00 PM
- Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis • Business Wire • 04/01/2024 12:00:00 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM